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Abstract
Apical ballooning syndrome (ABS) is a unique acute cardiac syndrome characterized by
symptoms and electrocardiographic changes that mimic acute myocardial infarction. It occurs
in patients without evidence of significant obstructive coronary artery disease and is asso-
ciated with transient extensive wall motion abnormalities of the apical and mid portions of the
left ventricle. The onset of ABS is preceded by a stressful event, either emotional or physical in
around 65% of cases. The underlying pathophysiology for ABS remains unclear; however,
several mechanisms have been proposed including multivessel epicardial spasm, microvascu-
lar spasm, catecholamine induced myocardial stunning and myocarditis. The treatment of
ABS remains entirely empirical and should be individualized according to the patient’s clini-
cal picture at the time of presentation. It should be initially managed according to the guide-
lines for acute coronary syndrome. Once the diagnosis of ABS is made, supportive care usually
leads to spontaneous recovery. The prognosis of patients with Takotsubo cardiomyopathy is
generally favourable. The left ventricular systolic dysfunction usually resolves within a few
weeks. In-hospital mortality is low, less than 2%, and recurrence rate is no more than 10%.
The aim of this article is to clarify, for the clinicians dealing with acute cardiac care, when they
should suspect ABS and how they should confirm the diagnosis and subsequently manage it.
(Cardiol J 2008; 15: 572–577)
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Introduction
Apical ballooning syndrome (ABS) is a unique
acute cardiac syndrome characterized by symptoms
and electrocardiographic (ECG) changes that mimic
acute myocardial infarction [1]. It occurs in patients
without evidence of significant obstructive corona-
ry artery disease and is associated with transient
extensive wall motion abnormalities of the apical
and mid portions of the left ventricle. Apical ballo-
oning syndrome was initially described in Japanese
patients in 1991 by Dote et al. [2], and was given
the name Takotsubo cardiomyopathy [3]. The latter
is a fishing pot with a round bottom and a narrow
neck that is used for trapping octopuses in Japan.
It was named so, on the basis of the characteristic
appearance of the left ventricle.
The current review article aims to clarify, for
the clinicians dealing with acute cardiac care,
when they should suspect ABS and how they sho-
uld confirm the diagnosis and subsequently ma-
nage it.
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Even though the exact prevalence of ABS re-
mains unknown, there is evidence to suggest that
it accounts for around 1% to 2% of patients who
present with a suspected acute myocardial infarc-
tion [4–6]. In a systemic review by Gianni et al. [1],
it was found that almost 90% of the patients with
ABS were women and more than 95% of them were
above the age of 50.
Chest pain is the most common presenting
complaint among patients with Takotsubo cardiomyo-
pathy [1, 5]. The second most common presenta-
tion is dyspnoea and other less frequent clinical
presentations include cardiogenic shock, syncope
and cardiac arrest [1, 7].
The onset of ABS is preceded by a stressful
event, either emotional (e.g. unexpected death of
a relative, financial crisis, catastrophic medical dia-
gnosis etc.) or physical (e.g. exhausting work, trau-
ma, exacerbation of a systemic disorder, etc) in aro-
und 65% of cases [1, 5]. In approximately 35% of
cases no trigger can be identified.
Investigations
Electrocardiographic features
The most frequent electrocardiographic chan-
ges are ST-segment elevation, usually in the precor-
dial leads, and T wave inversion (Fig. 1, 2) [1, 5].
However, the ECG could be normal or show non-
-specific changes.
Cardiac biomarkers and catecholamines
Troponin I or T and the MB fraction of CK are
usually only mildly raised in the majority of patients
[1, 8, 9]. Plasma levels of catecholamines have also
been found to be raised in most patients with ABS [1].
Echocardiography, left ventriculography
and coronary angiography
The latter shows no evidence of significant
coronary artery stenoses [3]. Echocardiography and
left ventriculography usually reveal marked left
ventricular dysfunction which is subsequently fol-
lowed by dramatic improvement over a period of
days to weeks [1]. The wall motion abnormalities
include moderate to severe dysfunction of the
Figure 1. Admission electrocardiogram of a patient who presented with chest pain reveals ST elevation in leads V1 to V3.
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mid-segment and the apical segment of the left ven-
tricle with sparing and usually hyperkinesis of the
basal segment (Fig. 3). The wall motion abnormali-
ties extend beyond the distribution of any single co-
ronary artery [5].
Cardiac magnetic resonance imaging
This technique is very useful because it can de-
monstrate preserved myocardial viability very well
and rule out myocardial infarction or myocarditis [8,
10–12].
Figure 2. Predischarge electrocardiogram of the same patient reveals T wave inversion in all the precordial leads.
Figure 3. Left ventriculography of the same patient, in diastole (A) and systole (B) reveals wall-motion abnormality
consistent with Takotsubo cardiomyopathy. The apical segment of the left ventricle is akinetic with sparing and
hyperkinesis of the basal segment.
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Pathophysiology
The underlying pathophysiology for Takotsubo
cardiomyopathy remains unclear; however several
mechanisms have been proposed including multi-
vessel epicardial spasm, microvascular spasm, ca-
techolamine induced myocardial stunning and my-
ocarditis [5].
Multivessel spasm has been postulated to be
the cause of ABC. Some investigators used provo-
cative tests, such as infusion of ergonovine, to in-
duce coronary spasm [1, 13, 14]. It was shown that
less than 30% of the evaluated patients experien-
ced multivessel spasm after infusion of a provoca-
tive agent. The latter suggests that large-vessel
spasm is an unlikely explanation of ABC in the
majority of patients.
Coronary microcirculation dysfunction is pre-
sent in the majority of patients who present with
this syndrome [4, 15, 16]. Ito et al showed that
myocardial perfusion assessed by single photon
emission computed tomography is impaired at the
time of presentation but improves considerably at
3–5 days [6]. In the absence of obstructive corona-
ry lesions, these findings suggest that impaired
microcirculation is the underlying cause of this syn-
drome. However, it is still not clear whether mi-
crovascular dysfunction is the primary mechanism
or is an epiphenomenon [5].
It has been suggested that enhanced sympathe-
tic activity plays an important role in the origin of
this syndrome [17]. ABS may result from stunning
of the myocardium in the setting of excess catecho-
lamines; however, it remains unclear whether the
catecholamine excess leads to microvascular spasm,
direct myocyte toxicity secondary to cyclic adenosine
monophosphate-mediated calcium overload or a pri-
mary metabolic abnormality [18, 19]. Bybee et al. [20]
found that in patients with ABS there is a flow-meta-
bolism mismatch pattern where there is preserved blo-
od flow but reduced glucose uptake. The enhanced ad-
renergic activity might lead to increased insulin resi-
stance which in turn leads to reduced glucose uptake.
Another explanation that has been suggested
is left ventricular outflow tract obstruction in the
setting of intense adrenergic activity or hypovole-
mia [9, 21]. Left ventricular outflow tract obstruc-
tion is known to be associated with increased wall
stress, raised left ventricular filling pressure and
decreased systemic blood pressure. These hemo-
dynamic changes, which are known to increase oxy-
gen demand and reduce coronary perfusion pres-
sure, may produce myocardial ischemia and subse-
quent stunning.
Myocarditis has also been proposed as a possi-
ble underlying cause. However, myocardial biopsies
and viral serology screens that have been perfor-
med on patients who have been diagnosed for ABS
have failed to show any evidence of myocarditis
[14, 16, 17]. Another enigmatic finding in patients
with ABS is the predilection of the apical and mid-
-segments of the left ventricle with sparing of the
basal segments. There is some evidence to suggest
that the apical region is more responsive to sym-
pathetic stimulation and more vulnerable to cate-
cholamine surges [22]. It has also been observed
that fatty acid metabolism, which is the predomi-
nant source of energy for the myocardium, is more
severely impaired than myocardial perfusion in the
mid and apical segments during the early phase of
this syndrome [23]. An alternative explanation is
that there are basal to apical gradients in both per-
fusion and sympathetic distribution [18, 20, 24].
A different mechanism that has been proposed
is that ABS may actually be the paradigm of spon-
taneously aborted myocardial infarction resulting
from an acute atherothrombotic event in the proxi-
mal or middle portion of the left anterior descen-
ding artery with subsequent rapid and complete
lysis of the thrombus [25]. This could be the case
in patients with long left anterior descending arte-
ries that wrap around the apex and supply a large
area of the inferior wall.
Discussion
The Mayo Clinic has recently proposed the
following diagnostic criteria for the clinical diagno-
sis of ABS [5]:
— Transient hypokinesis, akinesis or dyskinesis
of the left ventricular mid segments with or wi-
thout apical involvement. The regional wall-
motion abnormalities extend beyond a single
epicardial vascular distribution. However, the-
re are rare exceptions such as those patients
in whom the regional wall-motion abnormality
is limited to a single coronary territory.
— Absence of obstructive coronary disease or an-
giographic evidence of acute plaque rupture.
However, it is possible that a patient with ob-
structive coronary atherosclerosis may also
develop ABS. This is very rare in the published
literature, perhaps because such cases are mis-
diagnosed as an acute coronary syndrome. It
is obvious that in the above circumstances, the
diagnosis of ABS should be made with caution,
and a clear stressful precipitating trigger must
be sought [5].
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— New ECG abnormalities (either ST-segment
elevation and/or T-wave inversion) or elevated
cardiac troponin.
— Absence of recent significant head trauma, in-
tracranial bleeding, phechromocytoma, myo-
carditis and hypertrophic cardiomyopathy.
The treatment of ABS remains entirely empi-
rical and should be individualized according to the
patient’s clinical picture at the time of presentation.
It should be initially managed according to the gu-
idelines for acute coronary syndrome. Once the dia-
gnosis of ABS is made, supportive care usually le-
ads to spontaneous recovery [1, 5].
When there is significant hypotension, echo-
cardiography should be performed to rule out dy-
namic left ventricular outflow tract obstruction [5].
If present, it should be cautiously treated with beta-
blockers aiming to reduce the contractility of the
basal segment. Treatment with inotropes is contra-
indicated in this situation. If low blood pressure is
secondary to cardiogenic shock, treatment with ino-
tropes and intra-aortic balloon counterpulsation is
indicated [5, 9].
The prognosis of patients with Takotsubo car-
diomyopathy is generally favourable [5]. In-hospi-
tal mortality is low, less than 2%, and recurrence
rate is around 10% [1, 26]. Some centres advocate
long-term therapy with beta-blockers aiming in this
way to reduce the likelihood of recurrence [5].
It is almost certain that many patients over the
years have received thrombolysis which was tho-
ught to be successful even though it might have
been unnecessary, especially if we take into account
the suggested incidence of ABS, which is around 1%
to 2%, of patients who present with a suspected acute
myocardial infarction [5].
Therefore, physicians dealing with acute cardiac
care should be able to recognise the characteristic
features of this not so rare syndrome, provide sup-
portive therapy and proceed to urgent coronary an-
giography before giving thrombolytic therapy if the
diagnosis of ABS is strongly suspected.
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